Semaglutide, the active ingredient in Wegovy and Ozempic, belongs to a class of drugs that mimic glucagon-like peptide-1, a hormone the gut releases after eating
For those using semaglutide, tirzepatide, or other peptide therapies, maintaining a detailed health log can be instrumental
Additionally, the reassuring safety findings further support the strong potential value of semaglutide in this population. Chronic kidney disease affects over 800 million people worldwide and is particularly prevalent among individuals with type 2 diabetes.2 Chronic kidney disease poses a significant risk of kidney failure, cardiovascular events and death,3 highlighting the critical need for research into its prevention and treatment
Zepbound and Monjaro are intended for long-term use
Proper storage practices work hand-in-hand with genetic insights to maximize your personalized weight loss results